Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

NCT02617849 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Malignant Melanoma

Interventions

DRUG: Pembrolizumab
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Wilson Miller